Gamut Therapeutics
Latest round
- Seed
Last raised
- Feb 2021
Total raised
- $1.2M
Investors
- 1
About Gamut Therapeutics
Based in France, and founded in 2020, Gamut Therapeutics operates as a gene therapy company. Gamut Therapeutics The company is a spin-out of the Institut de la Vision in Paris. The company was founded by its CSO, Deniz Dalkara. In 2021, SparingVision SAS, a portfolio company of Bpifrance, Foundation Fighting Blindness, Jeito Capital, and The University of Pittsburgh Medical Center, acquired Gamut Therapeutics from AdBio Partners. The product line of Gamut Therapeutics includes SPVN20, which is an AAV (adeno-associated virus) vector-based gene therapy product that is used for the treatment of retinitis pigmentosa (RP). The company offers patients ocular genomic medicines that can revive dormant cone cells, which are healthy cones that have lost their ability to function because of degenerative retinal illnesses.
Who invested in Gamut Therapeutics
1 investor across 1 round
See all investors in Gamut Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 16, 2021
Amount
$1.2M
Investors
Questions about Gamut Therapeutics
Who invested in Gamut Therapeutics?
Gamut Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gamut Therapeutics raised?
Gamut Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gamut Therapeutics last raise money?
Gamut Therapeutics's most recent round on record is a Seed, in Feb 2021.
What does Gamut Therapeutics do?
Based in France, and founded in 2020, Gamut Therapeutics operates as a gene therapy company.
Where is Gamut Therapeutics headquartered?
Gamut Therapeutics is headquartered in France.
Which VCs invest in companies like Gamut Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Gamut Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Gamut Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.